BIIB Jan 2025 230.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:18AM EDT. Market open.
| Previous Close | 18.44 |
| Open | 18.36 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 230.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 18.36 - 18.63 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 154 |
ZacksThe Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
ZacksAlzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.
Investor's Business DailyEli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.
© 2024 Yahoo. All rights reserved.